Oasmia Pharmaceutical AB
Records under this name other than the patents Oasmia Pharmaceutical AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Oasmia Pharmaceutical AB
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE49,741 | Drug Delivery System for Administration of Poorly Water Soluble Pharmaceutically Active Substances Formerly held In force · Low confidence | In force | Low confidence | |
| US RE49,742 | Drug Delivery System for Administration of Poorly Water Soluble Pharmaceutically Active Substances Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,138,204 | Method for producing N-retinoylcysteic acid alkyl ester Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,322,996 | Method for producing N-retinoylcysteic acid alkyl ester Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,765,173 | Drug Delivery System for Administration of a Water Soluble, Cationic and Amphiphilic Pharmaceutically Active Substance Lapsed on the fee record Ended Jul 1, 2026 · High confidence | Lapsed on the fee record | Ended Jul 1, 2026 | High confidence |
| US 9,974,776 | Estrogen receptor beta agonists for use in treating mesothelioma Lapsed on the fee record Ended May 22, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2026 | From the USPTO record |
| US 8,367,665 | Estrogen receptor ligands Lapsed on the fee record Ended Feb 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 5, 2025 | From the USPTO record |
| US 9,993,438 | Drug Delivery System for Administration of Poorly Water Soluble Pharmaceutically Active Substances Formerly held Surrendered on reissue Surrendered on reissue Dec 5, 2023 · High confidence | Surrendered on reissue | Surrendered on reissue Dec 5, 2023 | High confidence |
| US 6,699,851 | Cytotoxic compounds and their use Term ended Term ended May 6, 2023 · From the USPTO record | Term ended | Term ended May 6, 2023 | From the USPTO record |
| US 7,030,158 | Therapeutic compounds Formerly held Term ended Term ended Apr 11, 2023 · From the USPTO record | Term ended | Term ended Apr 11, 2023 | From the USPTO record |